The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs – an HPLC-ICP-MS study

por Theiner, Sarah, Grabarics, Márkó, Galvez, Luis, Varbanov, Hristo P., Sommerfeld, Nadine S., Galanski, Mathea S., Keppler, Bernhard K., Koellensperger, Gunda
Publicado 2018

Nano-scale imaging of dual stable isotope labeled oxaliplatin in human colon cancer cells reveals the nucleolus as a putative node for therapeutic effect

por Legin, Anton A., Schintlmeister, Arno, Sommerfeld, Nadine S., Eckhard, Margret, Theiner, Sarah, Reipert, Siegfried, Strohhofer, Daniel, Jakupec, Michael A., Galanski, Mathea S., Wagner, Michael, Keppler, Bernhard K.
Publicado 2020

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform

por Lerchbammer-Kreith, Yvonne, Sommerfeld, Nadine S., Cseh, Klaudia, Weng-Jiang, Xian, Odunze, Uchechukwu, Schätzlein, Andreas G., Uchegbu, Ijeoma F., Galanski, Mathea S., Jakupec, Michael A., Keppler, Bernhard K.
Publicado 2023

Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents—A Novel Polymer Formulation for Anticancer Therapy

por Lerchbammer-Kreith, Yvonne, Hejl, Michaela, Sommerfeld, Nadine S., Weng-Jiang, Xian, Odunze, Uchechukwu, Mellor, Ryan D., Workman, David G., Jakupec, Michael A., Schätzlein, Andreas G., Uchegbu, Ijeoma F., Galanski, Mathea S., Keppler, Bernhard K.
Publicado 2023

Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo

por Schueffl, Hemma, Theiner, Sarah, Hermann, Gerrit, Mayr, Josef, Fronik, Philipp, Groza, Diana, van Schonhooven, Sushilla, Galvez, Luis, Sommerfeld, Nadine S., Schintlmeister, Arno, Reipert, Siegfried, Wagner, Michael, Mader, Robert M., Koellensperger, Gunda, Keppler, Bernhard K., Berger, Walter, Kowol, Christian R., Legin, Anton, Heffeter, Petra
Publicado 2021